BACKGROUND AND OBJECTIVES: Intradialytic hypertension is associated with adverse outcomes, yet the mechanism is uncertain. Patients with intradialytic hypertension exhibit imbalances in endothelial-derived vasoregulators nitric oxide and endothelin-1, indirectly suggesting endothelial cell dysfunction. We hypothesized that intradialytic hypertension is associated in vivo with endothelial cell dysfunction, a novel predictor of adverse cardiovascular outcomes. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: We performed a case-control cohort study including 25 hemodialysis (HD) subjects without (controls) and 25 with intradialytic hypertension (an increase in systolic BP pre- to postdialysis ≥10 mmHg ≥4/6 consecutive HD sessions). The primary outcome was peripheral blood endothelial progenitor cells (EPCs) assessed by aldehyde dehydrogenase activity (ALDH(br)) and cell surface marker expression (CD34(+)CD133(+)). We also assessed endothelial function by ultrasonographic measurement of brachial artery flow-mediated vasodilation (FMD) normalized for shear stress. Parametric and nonparametric t tests were used to compare EPCs, FMD, and BP. RESULTS: Baseline characteristics and comorbidities were similar between groups. Compared with controls, 2-week average predialysis systolic BP was lower among subjects with intradialytic hypertension (144.0 versus 155.5 mmHg), but postdialysis systolic BP was significantly higher (159.0 versus 128.1 mmHg). Endothelial cell function was impaired among subjects with intradialytic hypertension as measured by decreased median ALDH(br) cells and decreased CD34(+)CD133(+) cells (ALDH(br), 0.034% versus 0.053%; CD34(+)CD133(+), 0.033% versus 0.059%). FMD was lower among subjects with intradialytic hypertension (1.03% versus 1.67%). CONCLUSIONS: Intradialytic hypertension is associated with endothelial cell dysfunction. We propose that endothelial cell dysfunction may partially explain the higher event rates observed in these patients.
BACKGROUND AND OBJECTIVES: Intradialytic hypertension is associated with adverse outcomes, yet the mechanism is uncertain. Patients with intradialytic hypertension exhibit imbalances in endothelial-derived vasoregulators nitric oxide and endothelin-1, indirectly suggesting endothelial cell dysfunction. We hypothesized that intradialytic hypertension is associated in vivo with endothelial cell dysfunction, a novel predictor of adverse cardiovascular outcomes. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: We performed a case-control cohort study including 25 hemodialysis (HD) subjects without (controls) and 25 with intradialytic hypertension (an increase in systolic BP pre- to postdialysis ≥10 mmHg ≥4/6 consecutive HD sessions). The primary outcome was peripheral blood endothelial progenitor cells (EPCs) assessed by aldehyde dehydrogenase activity (ALDH(br)) and cell surface marker expression (CD34(+)CD133(+)). We also assessed endothelial function by ultrasonographic measurement of brachial artery flow-mediated vasodilation (FMD) normalized for shear stress. Parametric and nonparametric t tests were used to compare EPCs, FMD, and BP. RESULTS: Baseline characteristics and comorbidities were similar between groups. Compared with controls, 2-week average predialysis systolic BP was lower among subjects with intradialytic hypertension (144.0 versus 155.5 mmHg), but postdialysis systolic BP was significantly higher (159.0 versus 128.1 mmHg). Endothelial cell function was impaired among subjects with intradialytic hypertension as measured by decreased median ALDH(br) cells and decreased CD34(+)CD133(+) cells (ALDH(br), 0.034% versus 0.053%; CD34(+)CD133(+), 0.033% versus 0.059%). FMD was lower among subjects with intradialytic hypertension (1.03% versus 1.67%). CONCLUSIONS: Intradialytic hypertension is associated with endothelial cell dysfunction. We propose that endothelial cell dysfunction may partially explain the higher event rates observed in these patients.
Authors: Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel Journal: J Am Coll Cardiol Date: 2002-01-16 Impact factor: 24.094
Authors: Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel Journal: N Engl J Med Date: 2003-02-13 Impact factor: 91.245
Authors: Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig Journal: N Engl J Med Date: 2005-09-08 Impact factor: 91.245
Authors: Agnes Machnik; Anke Dahlmann; Christoph Kopp; Jennifer Goss; Hubertus Wagner; Nico van Rooijen; Kai-Uwe Eckardt; Dominik N Müller; Joon-Keun Park; Friedrich C Luft; Dontscho Kerjaschki; Jens Titze Journal: Hypertension Date: 2010-02-08 Impact factor: 10.190
Authors: M Cirit; F Akçiçek; E Terzioğlu; C Soydaş; E Ok; C F Ozbaşli; A Başçi; E J Mees Journal: Nephrol Dial Transplant Date: 1995 Impact factor: 5.992
Authors: G Bazzato; U Coli; S Landini; S Lucatello; A Fracasso; P Morachiello; F Righetto; F Scanferla Journal: Contrib Nephrol Date: 1984 Impact factor: 1.580
Authors: Ferdinand H Bahlmann; Kirsten de Groot; Ottfried Mueller; Barbara Hertel; Hermann Haller; Danilo Fliser Journal: Hypertension Date: 2005-03-14 Impact factor: 10.190
Authors: Sola Aoun Bahous; Antoine Stephan; Wadad Barakat; Jacques Blacher; Roland Asmar; Michel E Safar Journal: Kidney Int Date: 2004-10 Impact factor: 10.612
Authors: Noyan Gokce; John F Keaney; Liza M Hunter; Michael T Watkins; Zoran S Nedeljkovic; James O Menzoian; Joseph A Vita Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094
Authors: Gérard M London; Bruno Pannier; Mohsen Agharazii; Alain P Guerin; Francis H M Verbeke; Sylvain J Marchais Journal: Kidney Int Date: 2004-02 Impact factor: 10.612
Authors: Jula K Inrig; Peter Van Buren; Catherine Kim; Wanpen Vongpatanasin; Thomas J Povsic; Robert Toto Journal: Clin J Am Soc Nephrol Date: 2012-06-14 Impact factor: 8.237
Authors: Stephen M Ratchford; Ryan M Broxterman; D Taylor La Salle; Oh Sung Kwon; Song-Young Park; Paul N Hopkins; Russell S Richardson; Joel D Trinity Journal: Am J Physiol Heart Circ Physiol Date: 2019-10-04 Impact factor: 4.733
Authors: Meredith McAdams; L Parker Gregg; Rong Lu; Michael Concepcion; Swati Lederer; Jeff Penfield; Peter Noel Van Buren Journal: Clin Kidney J Date: 2020-09-06